[A new drug combination for the treatment of non-tubercular acute and chronic bronchopneumopathies].
Good therapeutic results free of unwanted side-effects were observed in the management of acute and chronic non-tubercular bronchopneumopathies with an association of tetracyclin hydrochloride, proteolytic enzymes (trypsin and chymotrypsin), vanillic acid diethylamide and pyridophyllin.
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D001991:Bronchitis / Q000188:drug therapy; D001996:Bronchopneumonia / Q000188:drug therapy; D002908:Chronic Disease; D002918:Chymotrypsin / Q000627:therapeutic use*; D004338:Drug Combinations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008169:Lung Abscess / Q000188:drug therapy; D008171:Lung Diseases / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013752:Tetracycline / Q000627:therapeutic use*; D014357:Trypsin / Q000627:therapeutic use*
D004338:Drug Combinations; D002918:Chymotrypsin; D014357:Trypsin; D013752:Tetracycline
Una nuova associazione medicamentosa per la cura dell broncopneumopatie acute e cronich non tubercolari